Advanced Malignancies and Hepatic Impairment
Oncology·MeSH: Lymphoma, Follicular
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| pelabresib | Novartis AG (NVS) |
Phase 1(1)
| Drug | Company |
|---|---|
| pelabresib | Novartis AG (NVS) |
Frequently asked questions
How many drugs are in development for Advanced Malignancies and Hepatic Impairment?
BioSniper tracks 2 drugs in development for Advanced Malignancies and Hepatic Impairment across 1 company.
How many clinical trials target Advanced Malignancies and Hepatic Impairment?
There are 1 clinical trial targeting Advanced Malignancies and Hepatic Impairment tracked by BioSniper.
Deep-dive into Advanced Malignancies and Hepatic Impairment
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis